Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 18975 | 461 | 29.7 | 68% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ZONISAMIDE | Author keyword | 202 | 60% | 48% | 219 |
| 2 | NEUROSCI MOL BIOL | Address | 7 | 46% | 2% | 11 |
| 3 | CA2 INDUCED CA2 RELEASING SYSTEM | Author keyword | 2 | 67% | 0% | 2 |
| 4 | ALKALINE URINE | Author keyword | 1 | 50% | 0% | 2 |
| 5 | CAS 68291 97 4 | Author keyword | 1 | 100% | 0% | 2 |
| 6 | CHILDRENS HOSP ANNA MEYER | Address | 1 | 100% | 0% | 2 |
| 7 | CLONIC CL SEIZURE | Author keyword | 1 | 100% | 0% | 2 |
| 8 | COUNCIL ON DENTAL THERAPEUTICS | Author keyword | 1 | 100% | 0% | 2 |
| 9 | IRON INDUCED EPILEPTOGENIC FOCI | Author keyword | 1 | 50% | 0% | 2 |
| 10 | PARADOXICAL INTOXICATION | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ZONISAMIDE | 202 | 60% | 48% | 219 | Search ZONISAMIDE | Search ZONISAMIDE |
| 2 | CA2 INDUCED CA2 RELEASING SYSTEM | 2 | 67% | 0% | 2 | Search CA2+INDUCED+CA2+RELEASING+SYSTEM | Search CA2+INDUCED+CA2+RELEASING+SYSTEM |
| 3 | ALKALINE URINE | 1 | 50% | 0% | 2 | Search ALKALINE+URINE | Search ALKALINE+URINE |
| 4 | CAS 68291 97 4 | 1 | 100% | 0% | 2 | Search CAS+68291+97+4 | Search CAS+68291+97+4 |
| 5 | CLONIC CL SEIZURE | 1 | 100% | 0% | 2 | Search CLONIC+CL+SEIZURE | Search CLONIC+CL+SEIZURE |
| 6 | COUNCIL ON DENTAL THERAPEUTICS | 1 | 100% | 0% | 2 | Search COUNCIL+ON+DENTAL+THERAPEUTICS | Search COUNCIL+ON+DENTAL+THERAPEUTICS |
| 7 | IRON INDUCED EPILEPTOGENIC FOCI | 1 | 50% | 0% | 2 | Search IRON+INDUCED+EPILEPTOGENIC+FOCI | Search IRON+INDUCED+EPILEPTOGENIC+FOCI |
| 8 | PARADOXICAL INTOXICATION | 1 | 50% | 0% | 2 | Search PARADOXICAL+INTOXICATION | Search PARADOXICAL+INTOXICATION |
| 9 | SEAL OF ACCEPTANCE | 1 | 100% | 0% | 2 | Search SEAL+OF+ACCEPTANCE | Search SEAL+OF+ACCEPTANCE |
| 10 | TONIC EXTENSOR TE SEIZURE | 1 | 100% | 0% | 2 | Search TONIC+EXTENSOR+TE+SEIZURE | Search TONIC+EXTENSOR+TE+SEIZURE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ADJUNCTIVE ZONISAMIDE | 38 | 93% | 3% | 14 |
| 2 | CI 912 | 37 | 100% | 3% | 14 |
| 3 | 3 SULFAMOYLMETHYL 1 2 BENZISOXAZOLE AD 810 | 21 | 90% | 2% | 9 |
| 4 | AD 810 | 17 | 79% | 2% | 11 |
| 5 | REFRACTORY PARTIAL SEIZURES | 7 | 15% | 9% | 42 |
| 6 | ANTICONVULSANT AGENT ZONISAMIDE | 5 | 50% | 2% | 7 |
| 7 | ANTICONVULSANT AGENT | 4 | 75% | 1% | 3 |
| 8 | ZONISAMIDE | 3 | 14% | 5% | 23 |
| 9 | JAPANESE EXPERIENCE | 2 | 20% | 2% | 7 |
| 10 | 3 SUBSTITUTED 1 2 BENZISOXAZOLE DERIVATIVES | 1 | 50% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Clinical pharmacology and mechanism of action of zonisamide | 2007 | 80 | 65 | 58% |
| The adverse event profile of zonisamide: a meta-analysis | 2013 | 5 | 37 | 89% |
| Zonisamide in the treatment of epilepsy | 2011 | 9 | 51 | 94% |
| Zonisamide: its pharmacology, efficacy and safety in clinical trials | 2012 | 13 | 48 | 88% |
| Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature | 2009 | 18 | 41 | 68% |
| Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety | 2008 | 22 | 76 | 72% |
| Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease | 2004 | 56 | 32 | 66% |
| Zonisamide in pediatric epilepsy: Re-view of the Japanese experience | 2002 | 41 | 36 | 56% |
| Open-label zonisamide for refractory migraine | 2004 | 42 | 10 | 80% |
| Zonisamide as a Treatment for Partial Epileptic Seizures: A Systematic Review | 2014 | 1 | 50 | 82% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEUROSCI MOL BIOL | 7 | 46% | 2.4% | 11 |
| 2 | CHILDRENS HOSP ANNA MEYER | 1 | 100% | 0.4% | 2 |
| 3 | BRAIN PEDIAT | 1 | 40% | 0.4% | 2 |
| 4 | BIOPOLAR DISORDER PROGRAM | 1 | 50% | 0.2% | 1 |
| 5 | BRANCH HOSP HOSP PHARM HIGASHI KU | 1 | 50% | 0.2% | 1 |
| 6 | DIAKONIE KORK | 1 | 50% | 0.2% | 1 |
| 7 | GROWTH DIFFERENTIAT | 1 | 50% | 0.2% | 1 |
| 8 | MED PUBL HLTH PSYCHIAT | 1 | 50% | 0.2% | 1 |
| 9 | MIDC IND ESTATE | 1 | 50% | 0.2% | 1 |
| 10 | PEDIAT SLEEP MED TRAINING PROGRAM | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000201274 | LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE |
| 2 | 0.0000154656 | TOPIRAMATE//TOPIRAMATE TOPAMAX//TOPIRAMATE TOXICITY |
| 4 | 0.0000101703 | LEVETIRACETAM//SV2A//BRIVARACETAM |
| 5 | 0.0000087813 | RUFINAMIDE//CLOBAZAM//LENNOX GASTAUT SYNDROME |
| 6 | 0.0000086352 | I 125 IOMAZENIL//ACQUISITION OF OPERANT BEHAVIOR//ACTIVE SHUTTLEBOX AVOIDANCE |
| 7 | 0.0000083937 | VET MED D426//VET EXTRA NEUROL//BROMIDE INTOXICATION |
| 8 | 0.0000080441 | ABNORMAL PLASTICITY//EL MOUSE//EPILEPTIC MUTANT |
| 9 | 0.0000072749 | LACOSAMIDE//ESLICARBAZEPINE ACETATE//PERAMPANEL |
| 10 | 0.0000070148 | EXPTL EPILEPSIEFOR//EXPERIMENTAL EPILEPSY MODELS//MODEL NERVOUS SYSTEM |